SCHEMBL6205902

SCHEMBL6205902

COC(O)Cc1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.50
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
IDO1 P14902 3/20 0.39
AGXT P21549 2/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38
TSHR P16473 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
CPA1 P15085 1/20 0.38
CA12 O43570 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204603 0.81 AGXT (0.40) IDO1AGXTPPARGPPARA
SCHEMBL9718322 0.80 TRPA1 (0.50) TRPA1NOS3NOS1NOS2IDO1
SCHEMBL6204427 0.79 LDHA (0.58) IDO1AGXTCA12CA7CA9
SCHEMBL20828503 0.79 LOXL2 (0.46) NOS3NOS1NOS2MAOBLOXL2
SCHEMBL6203597 0.79 MAOA (0.40) MAOAMAOB
SCHEMBL7268862 0.78 LAP3 (0.50) TRPA1MAOAPPARGPPARANPC1
SCHEMBL1279581 0.78 LAP3 (0.50) TRPA1MAOAPPARGPPARANPC1
SCHEMBL6204388 0.77 SLC1A1 (0.46) IDO1AGXTMAOAMAOBPPARG
SCHEMBL29107181 0.76 LPL (0.50) TSHR
SCHEMBL23347630 0.76 TRPA1 (0.61) TRPA1IDO1MAOAMAOBLOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed